Recent Updates
Recently added Catalysts

The Pennant Group, Inc.

PNTGFDA catalysts, PDUFA dates & pipeline intelligence
$35.94
▲ +0.03 · +0.07%

Financials

Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Quarterly Cash
Unlock full PNTG financials and dilution scoring
Quarter by quarter figures, cash trend and dilution risk.
Institutional-grade data · Cancel anytime
52W LOW $24.4652W HIGH $44.24
Volume
151.60 K
Value Traded
5.42 M
Short % Float
3.51%
Days to Cover
4.1
-1.43%Week
-12.2%1 Month
-8.85%3 Month
+0.82%6 Month

Cash Data

Unlock PNTG cash and runway
  • Monthly Burn
  • Burn Trend
  • Dilution Risk
  • SEC Filing

Key Stats

Market Cap
1.26 B
EPS (TTM)
1.02
P/E Ratio
35.10
Ent. Value
1.44 B
Total Shares
35.13 M
Float Shares
33.36 M
Insiders
5.06%
Institutions
88.73%

Upcoming Catalysts

FDA decisions, readouts and PDUFA dates · scored by probability of approval

Catalyst Drug / Treatment Stage Prob. of Approval Description Drug Type Therapeutic Area Source
Unlock every PNTG catalyst date and PoA score
Every FDA decision, readout and PDUFA date, with drug type, therapeutic area and a PoA score you can trade on.
Institutional-grade data · Cancel anytime
PoA blends historical approval base rates, trial design score and FDA review track record.

PNTG Catalyst Timeline

Dated clinical, regulatory and corporate events for The Pennant Group, Inc.

Unlock the full PNTG catalyst timeline
Every PDUFA date, readout, approval and corporate move, tiered by market impact and updated daily.
Institutional-grade data · Cancel anytime

Past FDA Catalysts and PDUFA Decisions

How PNTG actually traded into and out of each decision

Date Drug Catalyst Stage Reaction Event Move % Best Trade %
No matching catalysts
Unlock all PNTG historical catalysts
Institutional-grade data · Cancel anytime
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision

Drug Pipeline Intelligence

No drug pipeline

The Pennant Group, Inc. is a services and tools company (CRO, lab tools or healthcare services). The clinical trials it takes part in test other companies' drugs, so it has no drug pipeline of its own to score.

Clinical Trial Results

Readouts, endpoints and source filings for every PNTG program

Drug Name Indication Phase Date Trial Results SummaryTitleSource
Scroll for more · summaries link to the source press release
Unlock every PNTG trial readout
Institutional-grade data · Cancel anytime

Inside Trades

Unlock PNTG insider buying and selling
Monthly insider buys and sells against the stock price, with the insider sentiment reading.
Institutional-grade data · Cancel anytime
InsiderSideSharesPriceValueDate
Gochnour John JOfficer (Chief Operating Officer)Option 5,948 151,412 held$6.10 10/23/2026
Unlock the full PNTG insider trade log
Institutional-grade data · Cancel anytime

Hedge Fund 13F Activity

Fund % of Portfolio Current MV Shares Owned Activity
INTEGRAL HEALTH ASSET MANAGEMENT, LLC 1 % 7.36 M 180.00 K 125% ( 100.00 K)
Unlock every fund holding PNTG
Every 13F position with quarter over quarter share flow and average entry price.
Institutional-grade data · Cancel anytime
Unlock hedge fund flows in PNTG
Shares held by hedge funds each quarter, and who bought or sold.

Ownership Trends

Sign in to see PNTG ownership
Insider and institutional ownership, quarter by quarter.

PNTG Short Interest

Shares sold short, counted twice a month.

3.51%
Short % of Float
of tradable shares sold short
1.2M
Shares Sold Short
+2.0% vs prior count
4.1 Moderate
Days to Cover
trading days of normal volume to buy every short share back
288.4K
Avg Daily Volume
the average used for days to cover
Unlock PNTG short interest history
Two years of days to cover and shares sold short, with every count and its change.
Institutional-grade data · Cancel anytime

Options Data

Option Volume

Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg

Option Chain Statistics

ExpiryCall VolPut VolVol P/CCall OIPut OIOI P/CIV CallIV Call OI-WtdIV Call Vol-WtdIV PutIV Put OI-WtdIV Put Vol-Wtd
2026-11-20
Unlock PNTG option chain statistics
Per-expiry call and put volume, open interest, put-call ratios and implied volatility.
Institutional-grade data · Cancel anytime

Real-Time Option Chain

CallsStrikePuts
LastVolOILastVolOI
No data available
Unlock the live PNTG option chain
Live calls and puts by strike: last price, volume and open interest for every expiry.
Institutional-grade data · Cancel anytime

Calls vs Puts by Expiry

CallsPutsLog scale
Unlock PNTG options analytics
Institutional-grade data · Cancel anytime

Competitive positioning

How PNTG ranks across every disease it competes in

Competitive Position is a premium feature
See how PNTG ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial

PNTG News

-PNTG
Nov 13, 2026
PNTGConferences/Events
▲ +0.1%today

Pennant Group to Participate in the 2026 Stephens Annual Investment Conference

The Pennant Group, Inc. will participate in the 2026 Stephens Annual Investment Conference on November 17, 2026. CFO Lynette Walbom and COO John Gochnour will engage in a fireside chat at 11:45 a.m. Central Time. A live webcast of the event will be accessible online.

Read more →
-PNTG
Nov 4, 2026
PNTGGeneral
▼ -9.2%on this news

Pennant Reports Third Quarter 2026 Results

The Pennant Group reported strong third quarter results for 2026, with total revenue of $302.3 million, marking a 32.0% increase from the previous year. Net income reached $9.6 million, up 58.5%, while adjusted diluted earnings per share were $0.35. The company continues to expand its operations, adding new home health and hospice locations.

Read more →
-PNTG
Nov 3, 2026
PNTGGeneral
▲ +6.9%on this newsshared move

Pennant Announces Third Quarter 2026 Earnings Release and Call

The Pennant Group, Inc. announced plans to release its third quarter 2026 financial results on November 4, 2026. A live webcast for investors will follow on November 5, 2026, at 10:00 a.m. Mountain Time. Management will discuss the results from the second quarter during this session.

Read more →
-PNTG
Sep 16, 2026
PNTGGeneral
▼ -5.8%on this news

Pennant Acquires Real Estate of Mainplace Senior Living in Orange, California

The Pennant Group, Inc. has acquired the real estate of Mainplace Senior Living in Orange, California, effective September 3, 2026. This acquisition is part of Pennant's strategy to enhance its real estate portfolio and operational stability. The company aims to leverage established relationships in the community to create long-term value. Local leaders will continue to support Mainplace, ensuring continuity for residents and staff.

Read more →
-PNTG
Sep 1, 2026
PNTGConferences/Events

Pennant Group to Participate in the 2026 Jefferies Healthcare Services Conference

The Pennant Group, Inc. will participate in the 2026 Jefferies Healthcare Services Conference on September 15, 2026. CEO Brent Guerisoli and COO John Gochnour will engage in a fireside chat at 3:00 p.m. Central Time. A live webcast of the event will be available for interested parties.

Read more →
-PNTG
Aug 5, 2026
PNTGGeneral

Pennant Reports Second Quarter 2026 Results

The Pennant Group reported strong financial results for Q2 2026, with total revenue reaching $298.0 million, a 35.8% increase from the previous year. The company also saw significant growth in net income and adjusted earnings per share. Management is optimistic about exceeding their annual guidance, citing operational excellence and successful integration of recent acquisitions.

Read more →
-PNTG
Aug 4, 2026
PNTGGeneral

Pennant Acquires River Centre Assisted Living in Tucson, Arizona

The Pennant Group, Inc. has acquired River Centre Assisted Living in Tucson, Arizona, effective August 1, 2026. This acquisition adds a 63-unit assisted living community to Pennant's portfolio, enhancing its senior living operations. The company aims to ensure a smooth transition while maintaining a focus on personalized care for residents.

Read more →
-PNTG
Jul 28, 2026
PNTGGeneral

Pennant Announces Second Quarter 2026 Earnings Release and Call

The Pennant Group, Inc. (NASDAQ: PNTG) announced it will release its second quarter 2026 financial results on August 5, 2026. Following the release, a live webcast is scheduled for August 6, 2026, where management will discuss the results. The webcast will also be available for replay for a year.

Read more →
-PNTG
Jun 4, 2026
PNTGGeneral

The Pennant Group and Hartford HealthCare Expand Collaboration to Advance Home-Based Care in Connecticut

The Pennant Group and Hartford HealthCare have expanded their collaboration to enhance home-based care services in Connecticut. This partnership aims to create a nationally recognized model of home care, focusing on improved clinical outcomes and patient access. The collaboration has already led to a 4-star CMS rating for Hartford HealthCare at Home and plans for further investments in home-based care.

Read more →
-PNTG
Jun 3, 2026
PNTGGeneral

Pennant Expands Senior Living Presence with Pleasant Hill, California Community

The Pennant Group, Inc. has assumed operations of Memory Care of Contra Costa, a 46-unit memory care community in Pleasant Hill, California. This acquisition marks Pennant's first expansion into California since becoming independent in 2019. The company aims to maintain high-quality care and support for residents and staff during the transition.

Read more →
-PNTG
May 18, 2026
PNTGGeneral

Pennant Announces an Acquisition of Senior Living Community in Arizona

The Pennant Group, Inc. has announced the acquisition of Copper Canyon Memory Care in Tucson, Arizona, expanding its operations by 40 units. CEO Brent Guerisoli emphasized the strategic nature of this acquisition, which aligns with their disciplined capital deployment approach. The acquisition aims to enhance operational efficiency and improve resident outcomes in the Tucson community.

Read more →
-PNTG
May 18, 2026
PNTGConferences/Events

Pennant Group to Participate in the 2026 RBC Global Healthcare Conference

The Pennant Group, Inc. will participate in the 2026 RBC Global Healthcare Conference on May 20, 2026. Key executives, including the President and CFO, will engage in a fireside chat. The event aims to highlight the company's healthcare services and initiatives. A live webcast will be available for interested audiences.

Read more →
-PNTG
May 6, 2026
PNTGGeneral
▲ +9.8%on this news

Pennant Reports First Quarter 2026 Results

The Pennant Group reported strong first quarter results for 2026, with total revenue of $285.4 million, up 36.0% year-over-year. Net income reached $8.5 million, a 9.6% increase. Home health admissions rose significantly, reflecting operational growth. The company is integrating new operations while maintaining strong performance in existing segments.

Read more →
-PNTG
May 4, 2026
PNTGConferences/Events

Pennant Announces First Quarter 2026 Earnings Release and Call

The Pennant Group, Inc. (NASDAQ: PNTG) announced it will release its first quarter 2026 financial results on May 6, 2026. A live webcast is scheduled for May 7, 2026, where management will discuss these results. This event aims to engage current and prospective investors with detailed financial insights.

Read more →
-PNTG
May 1, 2026
PNTGGeneral

Pennant Acquires Senior Living Communities in Arizona and Wisconsin

The Pennant Group, Inc. has expanded its operations by acquiring three senior living communities in Arizona and Wisconsin, totaling 194 units. The communities will operate under new names, reflecting Pennant's commitment to quality care. CEO Brent Guerisoli emphasized the importance of disciplined growth and operational excellence in these transactions.

Read more →
-PNTG
Apr 1, 2026
PNTGGeneral

Pennant Acquires Arbor Rose Senior Living Community in Mesa, Arizona

The Pennant Group, Inc. has acquired Arbor Rose Senior Living in Mesa, Arizona, rebranding it as Lavender Lane Senior Living. This facility offers independent living, assisted living, and memory care services. The acquisition enhances Pennant's portfolio in the East Valley, reflecting its commitment to growth and quality care for seniors.

Read more →
-PNTG
Oct 1, 2019
PNTGGeneral

The Pennant Group, Inc. Announces Completion of Spin-off from The Ensign Group, Inc.

The Pennant Group, Inc. Announces Completion of Spin-off from The EAGLE, Idaho, October 1, 2019 The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of operating subsidiaries that provide home health, hospice and senior living services, announced today that it has success

Read more →

About The Pennant Group, Inc.

Eagle, ID 9,700 employees pennantgroup.com
Headquarters1675 E. RIVERSIDE DRIVE, EAGLE, ID, 83616
BIOPHARMAWATCH ELITE
Trade the next PNTG catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $24/mo billed annually.
Cancel anytime